Annual CFF
$133.41 M
+$132.94 M+27928.36%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual cash flow from financing activities is $133.41 million, with the most recent change of +$132.94 million (+27928.36%) on December 31, 2023.
- During the last 3 years, OLMA annual CFF has fallen by -$224.99 million (-62.78%).
- OLMA annual CFF is now -62.78% below its all-time high of $358.40 million, reached on December 31, 2020.
Performance
OLMA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$92.00 K
-$15.51 M-99.41%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly cash flow from financing activities is $92.00 thousand, with the most recent change of -$15.51 million (-99.41%) on September 30, 2024.
- Over the past year, OLMA quarterly CFF has dropped by -$130.54 million (-99.93%).
- OLMA quarterly CFF is now -99.96% below its all-time high of $219.79 million, reached on December 31, 2020.
Performance
OLMA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$25.04 M
-$130.54 M-83.90%
September 30, 2024
Summary
- As of February 7, 2025, OLMA TTM cash flow from financing activities is $25.04 million, with the most recent change of -$130.54 million (-83.90%) on September 30, 2024.
- Over the past year, OLMA TTM CFF has dropped by -$108.12 million (-81.20%).
- OLMA TTM CFF is now -93.01% below its all-time high of $358.40 million, reached on December 31, 2020.
Performance
OLMA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OLMA Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10000.0% | -99.9% | -81.2% |
3 y3 years | -62.8% | -99.9% | -81.2% |
5 y5 years | +2439.3% | -99.9% | -81.2% |
OLMA Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | -99.9% | +178.8% | -83.9% | +5160.7% |
5 y | 5-year | -62.8% | -100.0% | -100.0% | -100.0% | -93.0% | +5160.7% |
alltime | all time | -62.8% | -100.0% | -100.0% | -100.0% | -93.0% | -100.0% |
Olema Pharmaceuticals Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $92.00 K(-99.4%) | $25.04 M(-83.9%) |
Jun 2024 | - | $15.61 M(+76.9%) | $155.58 M(+9.5%) |
Mar 2024 | - | $8.82 M(+1586.6%) | $142.02 M(+6.4%) |
Dec 2023 | $133.41 M(>+9900.0%) | $523.00 K(-99.6%) | $133.41 M(+0.2%) |
Sep 2023 | - | $130.63 M(+6294.0%) | $133.16 M(+4940.3%) |
Jun 2023 | - | $2.04 M(+828.6%) | $2.64 M(+298.5%) |
Mar 2023 | - | $220.00 K(-19.4%) | $663.00 K(+39.3%) |
Dec 2022 | $476.00 K(-65.8%) | $273.00 K(+157.5%) | $476.00 K(-53.4%) |
Sep 2022 | - | $106.00 K(+65.6%) | $1.02 M(+5.0%) |
Jun 2022 | - | $64.00 K(+93.9%) | $972.00 K(-31.7%) |
Mar 2022 | - | $33.00 K(-96.0%) | $1.42 M(+2.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $1.39 M(-99.6%) | $818.00 K(+1335.1%) | $1.39 M(-99.4%) |
Sep 2021 | - | $57.00 K(-89.0%) | $220.36 M(-27.8%) |
Jun 2021 | - | $516.00 K(>+9900.0%) | $305.18 M(-7.1%) |
Mar 2021 | - | $0.00(-100.0%) | $328.42 M(-8.4%) |
Dec 2020 | $358.40 M(>+9900.0%) | $219.79 M(+159.0%) | $358.40 M(+158.6%) |
Sep 2020 | - | $84.87 M(+257.3%) | $138.61 M(+157.9%) |
Jun 2020 | - | $23.75 M(-20.8%) | $53.74 M(+79.2%) |
Mar 2020 | - | $29.99 M(>+9900.0%) | $29.99 M(>+9900.0%) |
Dec 2019 | $0.00(-100.0%) | - | - |
Sep 2019 | - | $0.00 | $0.00 |
Dec 2018 | $5.25 M | - | - |
FAQ
- What is Olema Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual CFF year-on-year change?
- What is Olema Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly CFF year-on-year change?
- What is Olema Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals TTM CFF year-on-year change?
What is Olema Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of OLMA is $133.41 M
What is the all time high annual CFF for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual cash flow from financing activities is $358.40 M
What is Olema Pharmaceuticals annual CFF year-on-year change?
Over the past year, OLMA annual cash flow from financing activities has changed by +$132.94 M (+27928.36%)
What is Olema Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of OLMA is $92.00 K
What is the all time high quarterly CFF for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly cash flow from financing activities is $219.79 M
What is Olema Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, OLMA quarterly cash flow from financing activities has changed by -$130.54 M (-99.93%)
What is Olema Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of OLMA is $25.04 M
What is the all time high TTM CFF for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high TTM cash flow from financing activities is $358.40 M
What is Olema Pharmaceuticals TTM CFF year-on-year change?
Over the past year, OLMA TTM cash flow from financing activities has changed by -$108.12 M (-81.20%)